HyamLevitskyMD

Physician

Dr. Levitsky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1988 - 1991
Johns Hopkins UniversityResidency, Internal Medicine, 1984 - 1987
Johns Hopkins University School of MedicineClass of 1984

PubMed

81 citations
Imaging CAR T cell therapy with PSMA-targeted positron emission tomography.
Il Minn, David Jeffrey Huss, Hye Hyun Ahn, Tamara M. Chinn, Andrew Park
Science Advances. 2019-07-01
142 citations
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity.
Sabine Hoves, Chia Huey Ooi, Carsten Wolter, Hadassah Sade, Stefan Bissinger
The Journal of Experimental Medicine. 2018-03-05
9 citations
Paradoxical decrease in the capture and lymph node delivery of cancer vaccine antigen induced by a TLR4 agonist as visualized by dual-mode imaging.
Deepak K. Kadayakkara, Michael J. Korrer, Jeff W.M. Bulte, Hyam I. Levitsky
Cancer Research. 2015-01-01

As Allogeneic Cell Therapy Approaches Flourish, Century Loads up $160M to Scale iPSC Platform for CAR-T, CAR-NKMarch 3rd, 2021
Century Therapeutics Launches with USD 250M Financing for Induced Pluripotent Stem Cell (iPSC) Allogeneic Cell Therapy PlatformJuly 1st, 2019
Bayer Powers Versant Cell Therapy Startup to $250M RoundJuly 1st, 2019

Immunologic Targets In Myeloid LeukemiaNational Cancer Institute2010–2012
Non-Invasive Quantification Of Vaccine-Mediated Antigen Delivery ToNational Cancer Institute2010–2011
Regulatory T Cells In B Cell LymphomaNational Cancer Institute2008–2011
Human ImmunologyNational Cancer Institute2006–2010
Vaccination In Combination With Imatinib Mesylate For Chronic Myeloid LeukemiaNational Center For Research Resources2007
K562/GM-CSF VaccinationNational Center For Research Resources2005–2006
Cancer Vaccines In The Treatment Of CMLNational Cancer Institute2004–2005
Immunotherapy For B Cell LymphomaNational Cancer Institute2002
Tumor VaccinesNational Cancer Institute1997–2002
Tumor Induced Antigen Specific T Cell ToleranceNational Cancer Institute1998–2000
Vaccine Strategies To Enhance CD4+ T Cell PrimingNational Institute Of Allergy And Infectious Diseases1995–1998
Novel T Cell Subset--Nk1+ Alpha BetaNational Cancer Institute1994–1995
Strategies For Enhancing Antigen Specific ImmunityNational Institute Of Allergy And Infectious Diseases1994
Analysis Of A Novel T Cell Subset--Nk1+ Alpha BetaNational Cancer Institute1991–1993